Neuroepithelioma  >>  Cilcane (cilengitide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cilcane (cilengitide) / Iceni Pharma
CENTRIC, NCT00689221 / 2007-004344-78: Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status

Completed
3
545
US, Europe
Cilengitide, Temozolomide, Radiotherapy
EMD Serono, European Organisation for Research and Treatment of Cancer - EORTC, Merck KGaA, Darmstadt, Germany
Glioblastoma
11/12
08/13

Download Options